Application of DASC and AUSC metrics in evaluating antimicrobial stewardship interventions in critically ill patients
Frontiers in Pharmacology · 06.11.2026 · 17
DOI: 10.3389/fphar.2026.1993215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 06.11.2026. Verfasst von Sisi Wang und 5 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Conventional metrics reflect use volume, not spectrum breadth, limiting de-escalation assessment. Using days of antibiotic spectrum coverage (DASC) and antibiotic spectrum coverage use (AUSC), we applied a dual-dimensional framework stratified by restriction level to evaluate the impact of antimicrobial stewardship interventions on consumption and spectrum coverage in critically ill patients with infections.
Methods
In this single-centre retrospective before–after intensive care unit study, an antimicrobial stewardship program optimized prescribing and reduced broad-spectrum exposure. Antimicrobial use was stratified by restriction level and evaluated using conventional metrics, spectrum-based metrics and derived ratio metrics.
Results
A total of 200 patients were included, and baseline characteristics were comparable between the two groups. Among 200 patients (100 per period), median DDDs decreased from 26.25 to 17.90 (r = 0.223, 95% CI 0.087–0.351; P = 0.002), DOT from 24.00 to 14.00 days (r = 0.294, 95% CI 0.162–0.420; P < 0.001), and DASC from 219.50 to 135.00 (r = 0.290, 95% CI 0.156–0.413; P < 0.001). No statistically significant between-period differences were detected for AUD, AUSC, DASC/DOT, or AUSC/AUD. In the non-special-use stratum, DASC (114.50–63.50; r = 0.242, 95% CI 0.106–0.368; P < 0.001), AUD (99.87–87.24; r = 0.157, 95% CI 0.018–0.289; P = 0.027), and AUSC (923.93–761.25; r = 0.151, 95% CI 0.012–0.284; P = 0.033) were lower in the intervention period; no statistically significant differences were detected in the special-use stratum. AUD correlated with AUSC (Spearman ρ = 0.75), as did AUSC with DASC (ρ = 0.40; both P < 0.01). Length of stay was also shorter (median 15.00 vs. 11.00 days; P < 0.001) and cumulative use correlated with it (ρ = 0.74–0.79); after accounting for observation time, only the treatment-day rate remained significantly lower (adjusted IRR 0.834, 95% CI 0.736–0.944, P = 0.004).
Conclusion
In this before-after study, cumulative DDDs, DOT, and DASC were lower during the intervention period, partly reflecting shorter length of stay. After adjustment, only the antibiotic treatment-day rate remained significantly lower, whereas DASC/DOT and AUSC/AUD were unchanged. DASC and AUSC may complement conventional metrics for describing spectrum exposure, but require further validation against prescribing appropriateness and clinical outcomes.
Zitieren
APA
Wang, S., Liu, Y., Wang, H., Yu, Y., Luo, C., & Hu, J. (2026). Application of DASC and AUSC metrics in evaluating antimicrobial stewardship interventions in critically ill patients. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1993215
Vancouver
Wang S, Liu Y, Wang H, Yu Y, Luo C, Hu J. Application of DASC and AUSC metrics in evaluating antimicrobial stewardship interventions in critically ill patients. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1993215
BibTeX
@article{Wang2026,
author = {Wang, Sisi and Liu, Yun and Wang, Han and Yu, Yuanyuan and Luo, Can and Hu, Jing},
title = {Application of DASC and AUSC metrics in evaluating antimicrobial stewardship interventions in critically ill patients},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1993215}
}
EUVIMED